High ROE & high ROCE multibagger stock with 2,000 per cent returns; Board announced stock split!

The stock gave multibagger returns of over 2,000 per cent in just 5 years whereas BSE small-cap Index is up by 157 per cent.

Gujarat Themis Biosyn Ltd announced that the Board of Directors of the company announced a sub-division/ stock split of every 1 fully paid-up equity share having a face value of Rs 5 each in the authorised share capital of the company, into 5 fully paid-up equity shares having face value of Rs 1 each as of record date. The company fixed the record date for the stock split as Tuesday, October 10, 2023.

On Friday, shares of Gujarat Themis Biosyn Ltd zoomed 1.31 per cent to Rs 871.30 per share with an intraday high of Rs 880.05 and an intraday low of Rs 855.20. The stock’s 52-week high is Rs 921.05 and its 52-week high is Rs 572.10 per share.

Incorporated in 1981, Gujarat Themis Biosyn Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process. The company has a market cap of Rs 1,266 crore and reported amazing numbers in its Quarterly Results and annual results. Further, the company has reduced its debt to almost zero and has achieved a compound annual growth rate (CAGR) of 71.8 per cent in profits over the last five years.

The shares of the company have an ROE of 45.9 per cent and an ROCE of 61.1 per cent. The stock gave multibagger returns of over 2,000 per cent in just 5 years whereas BSE Small-Cap Index is up by 157 per cent. Investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice.